Marshall Wace’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.1M | Buy |
2,300,554
+168,771
| +8% | +$1.92M | 0.03% | 441 |
|
|
2025
Q1 | $14.2M | Buy |
2,131,783
+1,180,351
| +124% | +$7.85M | 0.02% | 582 |
|
|
2024
Q4 | $10.5M | Sell |
951,432
-719,301
| -43% | -$7.93M | 0.01% | 719 |
|
|
2024
Q3 | $20.5M | Buy |
1,670,733
+509,696
| +44% | +$6.26M | 0.03% | 456 |
|
|
2024
Q2 | $15.7M | Buy |
1,161,037
+982,451
| +550% | +$13.3M | 0.02% | 518 |
|
|
2024
Q1 | $2.41M | Buy |
+178,586
| New | +$2.41M | ﹤0.01% | 1117 |
|
|
2023
Q4 | – | Sell |
-48,001
| Closed | -$189K | – | 2274 |
|
|
2023
Q3 | $189K | Buy |
+48,001
| New | +$189K | ﹤0.01% | 1676 |
|
|
2022
Q4 | – | Sell |
-20,617
| Closed | -$265K | – | 2810 |
|
|
2022
Q3 | $265K | Buy |
+20,617
| New | +$265K | ﹤0.01% | 2267 |
|
|
2022
Q2 | – | Sell |
-17,237
| Closed | -$362K | – | 3144 |
|
|
2022
Q1 | $362K | Sell |
17,237
-25,164
| -59% | -$528K | ﹤0.01% | 2215 |
|
|
2021
Q4 | $1.02M | Buy |
+42,401
| New | +$1.02M | ﹤0.01% | 1898 |
|